In Zucker diabetic fatty rats, a genetic rodent model for type 2 diabetes, the inhibition of dipeptidyl peptidase IV corrected glycemic dysmetabolism, hypertriglyceridemia, inflammation, and hypertension [11]. This evidence concerns the gene DPP4 and hypertensive disorder.